Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA01 CICLOSPORINUM CAPS. MOI 100 mg

EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS

S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALA 100 mg/ml

EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 25 mg

CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG

EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 50 mg

CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG

EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS

S.R.O.

SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________

______________________________________________________________________________

| 955 |L04AA05| TACROLIMUSUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul rejetului de alogrefă rezistent la alte